A citation-based method for searching scientific literature

Ali Movahed, Pema Raj, Iraj Nabipour, Marzieh Mahmoodi, Afshin Ostovar, Mohammadreza Kalantarhormozi, Thomas Netticadan. Nutrients 2020
Times Cited: 13







List of co-cited articles
76 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial.
Silvie Timmers, Marlies de Ligt, Esther Phielix, Tineke van de Weijer, Jan Hansen, Esther Moonen-Kornips, Gert Schaart, Iris Kunz, Matthijs K C Hesselink, Vera B Schrauwen-Hinderling,[...]. Diabetes Care 2016
62
38

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.
Pál Brasnyó, Gergo A Molnár, Márton Mohás, Lajos Markó, Boglárka Laczy, Judit Cseh, Esztella Mikolás, István András Szijártó, Akos Mérei, Richárd Halmai,[...]. Br J Nutr 2011
398
30

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers.
Luis Almeida, Manuel Vaz-da-Silva, Amílcar Falcão, Eva Soares, Raquel Costa, Ana I Loureiro, Carlos Fernandes-Lopes, José-Francisco Rocha, Teresa Nunes, Lyndon Wright,[...]. Mol Nutr Food Res 2009
265
23

Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats.
Mohamed M A Hussein, Mohamed K Mahfouz. Biomed Pharmacother 2016
25
23

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus.
Jayesh Kumar Bhatt, Sabin Thomas, Moola Joghee Nanjan. Nutr Res 2012
271
23

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.
Vernon W Dolinsky, Subhadeep Chakrabarti, Troy J Pereira, Tatsujiro Oka, Jody Levasseur, Donna Beker, Beshay N Zordoky, Jude S Morton, Jeevan Nagendran, Gary D Lopaschuk,[...]. Biochim Biophys Acta 2013
121
23

Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.
J Gambini, M Inglés, G Olaso, R Lopez-Grueso, V Bonet-Costa, L Gimeno-Mallench, C Mas-Bargues, K M Abdelaziz, M C Gomez-Cabrera, J Vina,[...]. Oxid Med Cell Longev 2015
269
23

The therapeutic potential of resveratrol: a review of clinical trials.
Adi Y Berman, Rachel A Motechin, Maia Y Wiesenfeld, Marina K Holz. NPJ Precis Oncol 2017
257
23

Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
Somayyeh Asghari, Maryam Rafraf, Laleh Farzin, Mohammad Asghari-Jafarabadi, Seyed-Mostafa Ghavami, Mohammad-Hossein Somi. Adv Pharm Bull 2018
22
23

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients.
Ali Movahed, Iraj Nabipour, Xavier Lieben Louis, Sijo Joseph Thandapilly, Liping Yu, Mohammadreza Kalantarhormozi, Seyed Javad Rekabpour, Thomas Netticadan. Evid Based Complement Alternat Med 2013
134
23

Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1.
Yuhua Chen, Jiao Meng, Hua Li, Hong Wei, Fangfang Bi, Shi Liu, Kai Tang, Haiyu Guo, Wei Liu. Exp Eye Res 2019
18
15

Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
Seth R Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das, Jost B Jonas, Jill Keeffe, John H Kempen,[...]. Lancet Glob Health 2017
831
15

Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats.
Farhad Ghadiri Soufi, Mina Vardyani, Roghayeh Sheervalilou, Mustafa Mohammadi, Mohammad Hussein Somi. Gen Physiol Biophys 2012
35
15

The Role of Resveratrol in Cancer Therapy.
Jeong-Hyeon Ko, Gautam Sethi, Jae-Young Um, Muthu K Shanmugam, Frank Arfuso, Alan Prem Kumar, Anupam Bishayee, Kwang Seok Ahn. Int J Mol Sci 2017
196
15


Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages.
Guozhu Ye, Guoyou Chen, Han Gao, Yi Lin, Xu Liao, Han Zhang, Xinyu Liu, Yulang Chi, Qiansheng Huang, Huimin Zhu,[...]. J Cell Mol Med 2019
14
15

Effect of food on the pharmacokinetic profile of trans-resveratrol.
M Vaz-da-Silva, A I Loureiro, A Falcao, T Nunes, J-F Rocha, C Fernandes-Lopes, E Soares, L Wright, L Almeida, P Soares-da-Silva. Int J Clin Pharmacol Ther 2008
61
15

Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Yang Sun, Qian-Mei Zhou, Yi-Yu Lu, Hui Zhang, Qi-Long Chen, Ming Zhao, Shi-Bing Su. Molecules 2019
24
15

Resveratrol supplementation improves metabolic control in rats with induced hyperlipidemia and type 2 diabetes.
Aleksandar Rašković, Veljko Ćućuz, Ljilja Torović, Ana Tomas, Ljiljana Gojković-Bukarica, Tatjana Ćebović, Boris Milijašević, Nebojša Stilinović, Jelena Cvejić Hogervorst. Saudi Pharm J 2019
10
20


Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.
David J Boocock, Guy E S Faust, Ketan R Patel, Anna M Schinas, Victoria A Brown, Murray P Ducharme, Tristan D Booth, James A Crowell, Marjorie Perloff, Andreas J Gescher,[...]. Cancer Epidemiol Biomarkers Prev 2007
524
15

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
M Jang, L Cai, G O Udeani, K V Slowing, C F Thomas, C W Beecher, H H Fong, N R Farnsworth, A D Kinghorn, R G Mehta,[...]. Science 1997
15


In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota.
Lisa M Bode, Diana Bunzel, Melanie Huch, Gyu-Sung Cho, Denise Ruhland, Mirko Bunzel, Achim Bub, Charles M A P Franz, Sabine E Kulling. Am J Clin Nutr 2013
181
15

Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
H Elbe, N Vardi, M Esrefoglu, B Ates, S Yologlu, C Taskapan. Hum Exp Toxicol 2015
71
15

Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets.
Maria Rotches-Ribalta, Cristina Andres-Lacueva, Ramon Estruch, Elvira Escribano, Mireia Urpi-Sarda. Pharmacol Res 2012
100
15

High absorption but very low bioavailability of oral resveratrol in humans.
Thomas Walle, Faye Hsieh, Mark H DeLegge, John E Oatis, U Kristina Walle. Drug Metab Dispos 2004
15

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway.
Li Yuan, Mengmeng Zhou, Dawei Huang, Harpreet S Wasan, Kai Zhang, Leitao Sun, Hong Huang, Shenglin Ma, Minhe Shen, Shanming Ruan. Mol Med Rep 2019
24
15

Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3.
Jinhua Li, Xinli Qu, Sharon D Ricardo, John F Bertram, David J Nikolic-Paterson. Am J Pathol 2010
139
15

Resveratrol attenuates the pathogenic and inflammatory properties of Porphyromonas gingivalis.
Amel Ben Lagha, Elisoa Andrian, Daniel Grenier. Mol Oral Microbiol 2019
9
22


The Global Epidemic of the Metabolic Syndrome.
Mohammad G Saklayen. Curr Hypertens Rep 2018
567
15

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
Beshay N M Zordoky, Ian M Robertson, Jason R B Dyck. Biochim Biophys Acta 2015
171
15


Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates.
Julie A Mattison, Mingyi Wang, Michel Bernier, Jing Zhang, Sung-Soo Park, Stuart Maudsley, Steven S An, Lakshmi Santhanam, Bronwen Martin, Shakeela Faulkner,[...]. Cell Metab 2014
131
15

Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome.
Eduardo Fuentes, Francisco Fuentes, Gemma Vilahur, Lina Badimon, Iván Palomo. Mediators Inflamm 2013
110
15

Resveratrol inhibits nonalcoholic fatty liver disease in rats.
Luis Bujanda, Elizabeth Hijona, Mikel Larzabal, Marta Beraza, Pablo Aldazabal, Nerea García-Urkia, Cristina Sarasqueta, Angel Cosme, Belen Irastorza, Alberto González,[...]. BMC Gastroenterol 2008
138
15

Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice.
Dong Wang, Shi-Ping Li, Jin-Sheng Fu, Sheng Zhang, Lin Bai, Li Guo. J Neurophysiol 2016
36
15

Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.
S-M Lee, H Yang, D M Tartar, B Gao, X Luo, S Q Ye, H Zaghouani, D Fang. Diabetologia 2011
84
15

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics.
Lynne M Howells, D P Berry, P J Elliott, E W Jacobson, E Hoffmann, B Hegarty, K Brown, W P Steward, A J Gescher. Cancer Prev Res (Phila) 2011
201
15

Resveratrol Exerts Antioxidant Effects by Activating SIRT2 To Deacetylate Prx1.
Yanchao Pan, Hua Zhang, Yueting Zheng, Juanzuo Zhou, Jing Yuan, Yang Yu, Jiangyun Wang. Biochemistry 2017
23
15

The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease.
Asma Hoseini, Gholamreza Namazi, Alireza Farrokhian, Željko Reiner, Esmat Aghadavod, Fereshteh Bahmani, Zatollah Asemi. Food Funct 2019
37
15

Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial.
S Bo, V Ponzo, G Ciccone, A Evangelista, F Saba, I Goitre, M Procopio, G F Pagano, M Cassader, R Gambino. Pharmacol Res 2016
69
15

Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats.
Roberta Schmatz, Luciane Belmonte Perreira, Naiara Stefanello, Cinthia Mazzanti, Roselia Spanevello, Jessié Gutierres, Margarete Bagatini, Caroline Curry Martins, Fátima Husein Abdalla, Jonas Daci da Silva Serres,[...]. Biochimie 2012
106
15

Resveratrol-Dependent Down-regulation of Receptor for Advanced Glycation End-products and Oxidative Stress in Kidney of Rats With Diabetes.
Heresh Moridi, Jamshid Karimi, Nasrin Sheikh, Mohammad Taghi Goodarzi, Massoud Saidijam, Reza Yadegarazari, Mohammad Khazaei, Iraj Khodadadi, Heidar Tavilani, Hossein Piri,[...]. Int J Endocrinol Metab 2015
39
15

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.
Sony S Thazhath, Tongzhi Wu, Michelle J Bound, Helen L Checklin, Scott Standfield, Karen L Jones, Michael Horowitz, Christopher K Rayner. Am J Clin Nutr 2016
51
15

Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.
Shan-Shan Huang, Da-Fa Ding, Sheng Chen, Cheng-Long Dong, Xiao-Long Ye, Yang-Gang Yuan, Ya-Min Feng, Na You, Jia-Rong Xu, Heng Miao,[...]. Sci Rep 2017
45
15

Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice.
Yuxin Xian, Yanyan Gao, Wenshan Lv, Xiaolong Ma, Jianxia Hu, Jingwei Chi, Wei Wang, Yangang Wang. Naunyn Schmiedebergs Arch Pharmacol 2020
5
40


Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.
Miriam Méndez-del Villar, Manuel González-Ortiz, Esperanza Martínez-Abundis, Karina G Pérez-Rubio, Roberto Lizárraga-Valdez. Metab Syndr Relat Disord 2014
103
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.